Ranitidine hydrochloride is an anti-ulcer agent commonly used to treat the symptoms of gastroesophageal reflux disease (GERD), peptic ulcers, and other acid reflux conditions. It is the hydrochloride salt of ranitidine, a histamine H2 receptor antagonist. Ranitidine HCl has a wide range of clinical applications in human medicine and veterinary medicine.
Ranitidine hydrochloride is used to treat ulcers and acid reflux conditions, by blocking the production of acid in the stomach. It is also used to treat erosive esophagitis, abdominal pain, indigestion, and dyspepsia, as well as to prevent the formation of gastric ulcers and reduce the acidity in the stomach. It is also sometimes used for the prevention of gastrointestinal bleeding.
| Brand Name | Anti-R |
|---|---|
| Type | Tablet |
| Weight | 150 mg |
| Generic | Ranitidine Hydrochloride |
| Manufacturer | United Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Ranitidine hydrochloride works by blocking the action of an enzyme in the stomach (called the histamine H2 receptor) that causes acid production. In blocking the action of this enzyme, the production of acid is reduced, reducing the symptoms of acid reflux and other acid-related conditions.
Ranitidine hydrochloride typically begins to work within 30 minutes of oral administration. However, it can take up to 4 hours for full effect.
Ranitidine hydrochloride is quickly and well absorbed from the gastrointestinal tract and reaches peak concentrations in the bloodstream after approximately 2 hours. It is then distributed throughout the body.
Ranitidine hydrochloride is eliminated mainly by hepatic metabolism and renal excretion. Approximately 85% of a dose of the drug is eliminated in the urine and 5-15% in the feces.
The recommended adult dosage for treating peptic ulcer disease is 150-300mg twice daily. For GERD, it is 300mg twice daily. The dosage of ranitidine hydrochloride for children and adolescents is 25 to 50 mg/kg per day administered in divided doses. The maximum daily dose should not exceed 6 g/day.
Ranitidine hydrochloride is available in tablet, capsule, syrup, and injection form. It should be orally administered with water or meals, depending on the doctor’s prescription. For injection form, it should be administered intravenously. It is also available as an oral solution.
Common side effects of ranitidine hydrochloride include: headaches, abdominal pain, diarrhea, nausea, vomiting, constipation, rash, and rarely, allergic reactions. Rare but serious side effects can include liver damage, reduction in white blood cells, and allergic reactions.
In case of an overdose, the symptoms may include abdominal pain, restlessness, confusion, nausea, vomiting, or diarrhea. An overdose of ranitidine hydrochloride may lead to an increase in acid levels in the blood and can be fatal without medical intervention.
Ranitidine hydrochloride should be used with caution in patients with renal or hepatic disease, and in the elderly. It should also be avoided in patients who have known hypersensitivity to ranitidine or any other component of the product.
Ranitidine hydrochloride may interact with other medications including anticoagulants, immunosuppressants, antifungals, and antibiotics. It is important to tell your doctor about any other medications you are taking before starting ranitidine hydrochloride, to avoid potential drug-drug interactions.
Ranitidine hydrochloride should be used cautiously in patients with pre-existing renal or hepatic disease. Patients with a history of cardiovascular disease or diabetes should consult a physician before taking ranitidine hydrochloride, as it may affect their condition.
Ranitidine hydrochloride may interact with other medications including anticoagulants, immunosuppressants, antifungals, and antibiotics. It is important to tell your doctor about any other medications you are taking before starting ranitidine hydrochloride, to avoid potential drug-drug interactions.
Ranitidine hydrochloride should be taken with food or immediately after a meal to ensure proper absorption. In some cases, a high fat or high protein meal may decrease the absorption of ranitidine hydrochloride, and so it should be taken at least 45 minutes after a meal.
Ranitidine hydrochloride should be used only if prescribed by a doctor during pregnancy. It is generally recommended to avoid the use of ranitidine in pregnant women, unless the benefit outweighs the risk.
Ranitidine hydrochloride should be avoided during breastfeeding, unless the benefit outweighs the risk. If it is prescribed, it should be taken after consulting a doctor.
In cases of an acute overdose, the symptoms may include abdominal pain, restlessness, confusion, nausea, vomiting, or diarrhea. An overdose of ranitidine hydrochloride may lead to an increase in acid levels in the blood and can be fatal without medical intervention.
Ranitidine hydrochloride is contraindicated in patients with known hypersensitivity to ranitidine or any other component of the product. It should also be used with caution in patients with renal or hepatic disease, and in the elderly.
Ranitidine hydrochloride should be taken exactly as prescribed by the doctor. It should be orally administered with water or meals, depending on the doctor’s prescription. For injection form, it should be administered intravenously. It is also available as an oral solution.
Ranitidine hydrochloride should be stored at room temperature, in a well-sealed container, away from excessive heat and moisture. Injection should be stored in the original package and should not be stored above 25°C (77°F).
Ranitidine hydrochloride has a volume of distribution of 0.5-1.3 L/kg.
The half-life of ranitidine hydrochloride is 1-2 hours.
The clearance rate of ranitidine hydrochloride is approximately 10-20 mL/min/kg.
See in details version Anti-R Tablet 150 mg also Anti-R Tablet 150 mg in bangla
Anti-R Tablet 150 mg is a medication classified as an H2 receptor antagonist (H2 blocker). It reduces stomach acid production and was widely used to treat conditions like heartburn, gastroesophageal reflux disease (GERD), and peptic ulcers. Sold under brand names like Zantac, it was available as tablets, syrup, or injections until its withdrawal from many markets in 2020 due to NDMA contamination concerns.
Ranitidine belongs to the H2 receptor blocker class. These drugs block histamine from binding to H2 receptors on parietal cells in the stomach, reducing acid secretion. It was a popular alternative to antacids and proton pump inhibitors (PPIs) for acid-related disorders.
Ranitidine works by competitively inhibiting histamine at the H2 receptors on gastric parietal cells. This reduces:
It was used for:
Off-label, it was sometimes used to prevent stress ulcers in critically ill patients or to reduce allergic reactions (due to histamine-blocking effects), though these uses were less common. Its primary role was acid suppression.
Ranitidine was taken orally as tablets (75 mg, 150 mg, 300 mg), syrup, or, in hospitals, via IV injection. It was typically taken once or twice daily, with or without food, depending on the condition and severity.
For adults:
For children (1 month and older):
Yes, it can be taken with or without food. Food doesn’t significantly affect absorption, though taking it before meals may enhance its effect on meal-induced acid production.
If you miss a dose, take it as soon as you remember unless it’s nearly time for the next dose. Skip it if it’s close, and don’t double up, as this could increase side effects like dizziness.
It reduces acid within 30–60 minutes, with peak effects in 2–3 hours. Relief from heartburn or indigestion is often felt within an hour, lasting up to 12 hours per dose.
Common side effects include:
Rare but serious side effects include:
In 2020, Ranitidine was recalled in many countries (e.g., U.S., EU) due to contamination with N-nitrosodimethylamine (NDMA), a probable carcinogen. NDMA levels increased over time, especially with heat exposure, prompting the FDA and other agencies to halt its sale.
Yes, though rare, it could cause rash, itching, or anaphylaxis in sensitive individuals. Those with histamine-related drug allergies were at higher risk.
It was contraindicated for:
It was Category B—generally safe based on animal studies, with limited human data. It was often used for pregnancy-related heartburn, but alternatives (e.g., antacids) are now preferred post-recall.
It passes into breast milk in small amounts but was considered safe. Post-recall, consult a doctor for safer options like famotidine.
Yes, it could affect:
Alcohol doesn’t interact directly, but it increases stomach acid and worsens GERD, countering Ranitidine’s benefits. Limit intake for best results.
No, it doesn’t affect metabolism or cause weight gain. Any perceived change might be from reduced bloating or diet.
Yes, a common dose (e.g., 300 mg) was taken at bedtime to control nighttime acid reflux and promote ulcer healing.
Duration varied:
Yes, stopping poses no withdrawal risk, but acid rebound might worsen symptoms if the underlying issue persists.
No, it doesn’t directly impact blood sugar. Diabetics could use it safely for acid issues.
The NDMA contamination raised cancer concerns (e.g., stomach, liver cancer) with long-term use. While no definitive link was proven in humans, this led to its withdrawal. Alternatives lack this risk.
Avoid:
Fatigue was rare but reported, possibly from dizziness or underlying conditions, not a primary effect.
Yes, but dose adjustments were needed for reduced kidney function in the elderly to avoid accumulation.
Rarely, it could cause reversible liver enzyme elevations. Significant damage was uncommon unless liver disease pre-existed.
Yes, for infants (1 month+) and children, with doses of 2–4 mg/kg twice daily for ulcers or GERD, under medical supervision.
Maximum was 600 mg daily (e.g., for Zollinger-Ellison), typically divided into doses, though 300 mg daily was common for most uses.
Yes, dizziness was a mild side effect, especially in higher doses or the elderly, likely from systemic effects.
Ranitidine (H2 blocker) reduces acid by blocking histamine, acting faster but less potently than PPIs (e.g., omeprazole), which inhibit the proton pump directly and last longer.
Yes, it was used to prevent NSAID-induced or stress ulcers in high-risk patients, though PPIs are now preferred.
No, it has no effect on cholesterol levels.
Yes, but space them 1–2 hours apart, as antacids may reduce Ranitidine absorption if taken simultaneously.
For long-term use, monitor:
No, it’s not linked to depression. Mood changes would be unrelated.
No, it’s not addictive, though stopping might lead to acid rebound if used long-term.
Yes, tablets could be crushed if swallowing was hard, though a syrup form was available.
Hair loss was extremely rare and not a confirmed side effect.
Off-label, it was sometimes used with H1 blockers (e.g., diphenhydramine) for allergic reactions, but this was uncommon.
Its half-life is 2–3 hours, longer with kidney impairment, supporting twice-daily dosing.
Yes, a mild rash was possible, and a severe rash might indicate an allergy—stop use and seek help.
No direct effect, but relieving acid reflux might improve exercise comfort.
Yes, it could reduce aspirin-induced stomach irritation, with no major interaction.
Before recall, it was affordable ($5–$15/month as generic). Alternatives like famotidine are now similarly priced.
Rarely, mild stomach discomfort occurred, but it was meant to relieve such pain.
Store at room temperature (15–30°C or 59–86°F), away from moisture and heat. Avoid high temperatures to limit NDMA formation (pre-recall concern).